Consequences of conversion from cyclosporine to conventional therapy in renal transplantation.
Abbud-Filho
M
M
Instituto de Urologia e Nefrologia, São Jośe do Rio Preto, São Paulo, Brazil.
Barberato
J B
JB
Ramalho
H J
HJ
Saldanha
L B
LB
Casassanta
D M
DM
Denadai
E R
ER
Zerati
S
S
Bezas
A G
AG
D001379:Azathioprine / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D016030:Kidney Transplantation; D011188:Potassium / Q000097:blood; D011241:Prednisone / Q000627:therapeutic use*
D003524:Cyclosporins; D003404:Creatinine; D001379:Azathioprine; D011188:Potassium; D011241:Prednisone